PT81093A - Tumortherapeutikum und verfahren zu seiner herstellung - Google Patents

Tumortherapeutikum und verfahren zu seiner herstellung

Info

Publication number
PT81093A
PT81093A PT81093A PT8109385A PT81093A PT 81093 A PT81093 A PT 81093A PT 81093 A PT81093 A PT 81093A PT 8109385 A PT8109385 A PT 8109385A PT 81093 A PT81093 A PT 81093A
Authority
PT
Portugal
Prior art keywords
production
therapeutic process
tumor therapeutic
monoclonal antibodies
antigens
Prior art date
Application number
PT81093A
Other languages
German (de)
English (en)
Other versions
PT81093B (pt
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of PT81093A publication Critical patent/PT81093A/pt
Publication of PT81093B publication Critical patent/PT81093B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Window Of Vehicle (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PT81093A 1984-09-06 1985-09-05 Processo para a preparacao de uma composicao terapeutica para tratamento de um tumor PT81093B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843432714 DE3432714A1 (de) 1984-09-06 1984-09-06 Tumortherapeutikum und verfahren zu seiner herstellung

Publications (2)

Publication Number Publication Date
PT81093A true PT81093A (de) 1985-10-01
PT81093B PT81093B (pt) 1988-07-01

Family

ID=6244749

Family Applications (1)

Application Number Title Priority Date Filing Date
PT81093A PT81093B (pt) 1984-09-06 1985-09-05 Processo para a preparacao de uma composicao terapeutica para tratamento de um tumor

Country Status (13)

Country Link
EP (1) EP0173951B1 (pt)
JP (1) JPS6168427A (pt)
AT (1) ATE64531T1 (pt)
CA (1) CA1277600C (pt)
DE (2) DE3432714A1 (pt)
DK (1) DK172253B1 (pt)
ES (1) ES8704082A1 (pt)
FI (1) FI88360C (pt)
GR (1) GR852149B (pt)
IE (1) IE58638B1 (pt)
IL (1) IL76289A (pt)
PT (1) PT81093B (pt)
ZA (1) ZA856807B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3806565A1 (de) * 1988-03-01 1989-09-14 Deutsches Krebsforsch Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen
AT398900B (de) * 1991-02-12 1995-02-27 Pekar Rudolf Dr Vakzine für eine immuntherapie
US6953668B1 (en) 1992-11-05 2005-10-11 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen
US7070782B1 (en) 1992-11-05 2006-07-04 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen
US7105159B1 (en) 1992-11-05 2006-09-12 Sloan-Kettering Institute For Cancer Research Antibodies to prostate-specific membrane antigen
PT668777E (pt) * 1992-11-05 2007-01-31 Sloan Kettering Inst Cancer Antigenio de membrana especifico para a prostata
US6569432B1 (en) 1995-02-24 2003-05-27 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
DE19506483A1 (de) * 1995-02-24 1996-08-29 Jens Dr Dr Atzpodien Lyophilisat-Vakzine
DE69635801T2 (de) 1995-02-24 2006-11-02 Sloan-Kettering Institute For Cancer Research Prostataspezifisches membranes antigen und seine anwendungen
EP3184539A3 (en) 2001-10-23 2017-09-13 PSMA Development Company L.L.C. Psma antibodies
US20050215472A1 (en) 2001-10-23 2005-09-29 Psma Development Company, Llc PSMA formulations and uses thereof
CN1315536C (zh) * 2002-09-13 2007-05-16 李进 肿瘤抗原疫苗及其制备方法和疫苗组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm
DE2643215A1 (de) * 1976-09-25 1978-04-06 Bayer Ag Cancerostatisch wirksame praeparationen aus tumorzellen und ein verfahren zu ihrer herstellung
ZA776822B (en) * 1976-11-24 1979-06-27 D Mccollester Vaccine and method for immunotherapy of neoplastic disease
DE2918927A1 (de) * 1979-05-10 1980-11-20 Hans Prof Dr Limburg Arzneipraeparat zur behandlung von carcinomen und verfahren zu dessen herstellung
US4446122A (en) * 1979-12-28 1984-05-01 Research Corporation Purified human prostate antigen
US4468457A (en) * 1981-06-01 1984-08-28 David M. Goldenberg Method for producing a CSAp tryptic peptide and anti-CSAp antibodies
DE3416774A1 (de) * 1984-05-07 1985-11-14 Behringwerke Ag, 3550 Marburg Monoklonale antikoerper, verfahren zu ihrer herstellung sowie ihre verwendung
DE3329184A1 (de) * 1983-08-12 1985-02-21 Behringwerke Ag, 3550 Marburg Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene

Also Published As

Publication number Publication date
FI853389A0 (fi) 1985-09-04
ZA856807B (en) 1986-04-30
DE3583265D1 (de) 1991-07-25
IE58638B1 (en) 1993-10-20
DE3432714A1 (de) 1986-04-24
ES546701A0 (es) 1987-03-16
ES8704082A1 (es) 1987-03-16
JPS6168427A (ja) 1986-04-08
ATE64531T1 (de) 1991-07-15
EP0173951A3 (en) 1988-06-08
DK172253B1 (da) 1998-02-09
FI88360B (fi) 1993-01-29
DK402485D0 (da) 1985-09-03
IL76289A0 (en) 1986-01-31
PT81093B (pt) 1988-07-01
FI853389L (fi) 1986-03-07
CA1277600C (en) 1990-12-11
FI88360C (fi) 1993-05-10
IE852191L (en) 1986-03-06
EP0173951B1 (de) 1991-06-19
DK402485A (da) 1986-03-07
IL76289A (en) 1992-01-15
EP0173951A2 (de) 1986-03-12
GR852149B (pt) 1986-01-03

Similar Documents

Publication Publication Date Title
DE3770239D1 (de) Mundstueck und verfahren zum herstellen von diesem.
FI101937B1 (fi) Menetelmä monoklonaalisen vasta-aineen tuottamiseksi, joka reagoi ihmisen cachectiinin kanssa
ATE168131T1 (de) T-cadherin-bindungsmolekül
IT8319234A0 (it) Procedimento per la produzione di anticorpi monoclonali umani.
NO175964C (no) Analogifremgangsmåte til fremstilling av en terapeutisk aktiv, platinaholdig, makromolekylær, kompleks sammensetning
DE3673073D1 (de) Therapeutische brausemischung sowie verfahren zu deren herstellung.
PT81093A (de) Tumortherapeutikum und verfahren zu seiner herstellung
HUT71193A (en) Tumor specific monoclonal antibody and cell line and pharmaceutical preparations containing them
DE3861164D1 (de) Verfahren zum herstellen von sphaerischen teilchen.
DE3578438D1 (de) Verbessertes siliziumoxynitrid-material und verfahren zu dessen herstellung.
EP0194851A3 (en) Human tumor therapy
DE3583891D1 (de) Monoklonaler menschlicher anti-igg-koerper und verfahren zu seiner herstellung.
EP0268640A4 (en) VACCINE STIMULATING OR IMPROVING THE PRODUCTION OF ANTIBODIES AGAINST GM2.
AT363487B (de) Verfahren zum herstellen von neuen amino-pyrazolo(1,5-a)s.triazinen
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
AT387577B (de) Verfahren zur herstellung von n-alkyl/en/-n-/o,o- disubstituierten thiophosphoryl/-n'n'disubstituierten-glycinamiden und diese verbindungen enthaltende akarizide, insektizide und fungizide mittel
ATA459980A (de) Verfahren zur herstellung des neuen vitam d3derivates 1alpha,25,26-trihydroxycholecalciferol
PT76582B (de) 1,2,4-triazol-1-yl-propionitrile verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
DE3777245D1 (de) Protein und verfahren zu dessen herstellung.
NL189358C (nl) Werkwijze voor het bereiden van een geneesmiddel voor de behandeling van kanker, alsmede een van een 1,3-alkaandiamine afgeleid platina-diamminecomplex.
DE3784502D1 (de) Monoklonaler antikoerper, verfahren zu seiner herstellung und diagnostikum, das ihn enthaelt.
IL67944A0 (en) Antibodies and antigens useful in the diagnosis and treatment of cancer,methods for the production thereof and methods for testing for the presence of cancer cells using the same
ATE12001T1 (de) Peptid, verfahren zu dessen herstellung und verwendung.
MC1653A1 (fr) Antigene viral,son procede d'obtention et son application diagnostique et therapeutique
DE3583356D1 (de) Wasserstoffbehandlungskatalysator und verfahren zu dessen herstellung.

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20020630